Joseph M. Kelly

Person

Cambridge, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Inhibitors of histone deacetylase useful for the treatment or preve...
- Patent number 12,331,044
- Issue date Jun 17, 2025
- Merck Sharp & Dohme LLC
- Jian Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of histone deacetylase-3 useful for the treatment of can...
- Patent number 12,281,109
- Issue date Apr 22, 2025
- Merck Sharp & Dohme LLC
- Jian Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted imidazo[1,2-c]quinazolines as A2A antagonists
- Patent number 11,498,923
- Issue date Nov 15, 2022
- Merck Sharp & Dohme LLC
- Yeon-Hee Lim
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine com...
- Patent number 9,676,780
- Issue date Jun 13, 2017
- Merck Sharp & Dohme Corp.
- Amjad Ali
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds that are ERK inhibitors
- Patent number 8,999,966
- Issue date Apr 7, 2015
- Merck Sharp & Dohme Corp.
- Sobhana Babu Boga
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic compounds as ERK inhibitors
- Patent number 8,999,957
- Issue date Apr 7, 2015
- Merck Sharp & Dohme Corp.
- Yongqi Deng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds that are ERK inhibitors
- Patent number 8,546,404
- Issue date Oct 1, 2013
- Merck Sharp & Dohme
- Alan B. Cooper
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds that are ERK inhibitors
- Patent number 7,807,672
- Issue date Oct 5, 2010
- Schering Corporation
- Yongqi Deng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bipiperdine derivatives useful as CCR3 antagonists
- Patent number 7,705,153
- Issue date Apr 27, 2010
- Schering Corporation
- Pauline C. Ting
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted urea neuropeptide Y Y5 Receptor antagonists
- Patent number 6,894,063
- Issue date May 17, 2005
- Schering Corporation
- William J. Greenlee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Farnesyl protein transferase inhibitors
- Patent number 6,800,636
- Issue date Oct 5, 2004
- Schering Corporation
- Timothy Guzi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Farnesyl protein transferase inhibitors
- Patent number 6,740,661
- Issue date May 25, 2004
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the inhibition of farnesyl protein transferase
- Patent number 6,576,639
- Issue date Jun 10, 2003
- Schering Corporation
- Ronald J. Doll
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Phenyl-substituted tricyclic inhibitors of farnesyl-protein transfe...
- Patent number 6,440,989
- Issue date Aug 27, 2002
- Schering Corporation
- Adriano Afonso
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Farnesyl protein transferase inhibitors
- Patent number 6,372,747
- Issue date Apr 16, 2002
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Farnesyl protein transferase inhibitors
- Patent number 6,362,188
- Issue date Mar 26, 2002
- Schering Corporation
- Timothy Guzi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Phenyl-substituted tricyclic inhibitors of farnesyl-protein transfe...
- Patent number 6,218,401
- Issue date Apr 17, 2001
- Schering Corporation
- Adriano Afonso
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic amides useful for inhibition of G-protein function and fo...
- Patent number 6,214,828
- Issue date Apr 10, 2001
- Schering Corporation
- Ronald J. Doll
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic amides useful for inhibition of G-protein function and fo...
- Patent number 6,143,758
- Issue date Nov 7, 2000
- Schering Corporation
- Ronald J. Doll
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic compounds having activity as RAS-FPT inhibitors
- Patent number 6,130,229
- Issue date Oct 10, 2000
- Schering Corporation
- Adriano Afonso
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic compounds useful for inhibition of a g-protein function a...
- Patent number 5,958,939
- Issue date Sep 28, 1999
- Schering Corporation
- Adriano Afonso
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tricyclic amides useful for inhibition of G-protein function and fo...
- Patent number 5,874,442
- Issue date Feb 23, 1999
- Schering-Plough Corporation
- Ronald J. Doll
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-substituted pyrazoloquinoline derivatives
- Patent number 5,786,480
- Issue date Jul 28, 1998
- Schering Corporation
- Adriano Afonso
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic compounds useful for inhibition of G-protein function and...
- Patent number 5,703,090
- Issue date Dec 30, 1997
- Schering Corporation
- Adriano Afonso
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tricyclic compounds useful for inhibition of g-protein function and...
- Patent number 5,684,013
- Issue date Nov 4, 1997
- Schering Corporation
- Adriano Afonso
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
4-substituted pyrazoloquinoline derivatives
- Patent number 5,608,067
- Issue date Mar 4, 1997
- Adriano Afonso
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazoloquinolines
- Patent number 5,595,998
- Issue date Jan 21, 1997
- Ronald L. Wolin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-substituted pyrazoloquinoline derivatives
- Patent number 5,506,236
- Issue date Apr 9, 1996
- Schering Corporation
- Adriano Afonso
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-substituted pyrazoloquinoline derivatives
- Patent number 5,459,146
- Issue date Oct 17, 1995
- Schering Corporation
- Adriano Afonso
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ADENOSINE A2A AND A2B RECEPTOR DUAL ANTAGONISTS FOR IMMUNO-ONCOLOGY
- Publication number 20240076297
- Publication date Mar 7, 2024
- Merck Sharp & Dohme LLC
- Amjad Ali
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ADENOSINE A2A AND A2B RECEPTOR DUAL ANTAGONISTS FOR IMMUNO-ONCOLOGY
- Publication number 20230322785
- Publication date Oct 12, 2023
- Merck Sharp & Dohme LLC
- Amjad Ali
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF HISTONE DEACETYLASE-3 USEFUL FOR THE TREATMENT OF CAN...
- Publication number 20220177465
- Publication date Jun 9, 2022
- MERCK SHARP & DOHME CORP.
- Jian LIU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF HISTONE DEACETYLASE USEFUL FOR THE TREATMENT OR PREVE...
- Publication number 20210276992
- Publication date Sep 9, 2021
- MERCK SHARP & DOHME CORP.
- Jian Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZO[1,2-C]QUINAZOLIN-5-AMINE COMPOUNDS WITH A2A ANTAGONIST PROP...
- Publication number 20210053973
- Publication date Feb 25, 2021
- MERCK SHARP & DOHME CORP.
- Amjad ALI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PIPERAZINE-SUBSTITUTED [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINE COM...
- Publication number 20160194330
- Publication date Jul 7, 2016
- MERCK SHARP & DOHME CORP.
- Amjad Ali
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS THAT ARE ERK INHIBITORS
- Publication number 20130237518
- Publication date Sep 12, 2013
- Merck Sharp & Dohme Corp.
- Sobhana Babu Boga
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL HETEROCYCLIC COMPOUNDS AS ERK INHBITORS
- Publication number 20130096084
- Publication date Apr 18, 2013
- Yongqi Deng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL COMPOUNDS THAT ARE ERK INHIBITORS
- Publication number 20110189192
- Publication date Aug 4, 2011
- Alan B. Cooper
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AND USE THEREOF AS ERK INHIBITORS
- Publication number 20110038876
- Publication date Feb 17, 2011
- Robert Sun
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel compounds that are ERK inhibitors
- Publication number 20090118284
- Publication date May 7, 2009
- Alan B. Cooper
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel compounds that are ERK inhibitors
- Publication number 20070232610
- Publication date Oct 4, 2007
- Yongqi Deng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Farnesyl protein transferase inhibitors
- Publication number 20070213340
- Publication date Sep 13, 2007
- Joseph M. Kelly
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel compounds that are ERK inhibitors
- Publication number 20070191604
- Publication date Aug 16, 2007
- Alan Cooper
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperdine derivatives useful as CCR3 antagonists
- Publication number 20050182095
- Publication date Aug 18, 2005
- Schering Corporation
- Pauline C. Ting
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted urea neuropeptide Y Y5 receptor antagonists
- Publication number 20050038100
- Publication date Feb 17, 2005
- William J. Greenlee
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted urea neuropeptide Y Y5 receptor antagonists
- Publication number 20030114517
- Publication date Jun 19, 2003
- William J. Greenlee
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Farnesyl protein transferase inhibitors
- Publication number 20030040520
- Publication date Feb 27, 2003
- Timothy Guzi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted urea neuropeptide Y Y5 receptor antagonists
- Publication number 20020165223
- Publication date Nov 7, 2002
- William J. Greenlee
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Farnesyl protein transferase inhibitors
- Publication number 20020103207
- Publication date Aug 1, 2002
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY

Joseph M. Kelly

Person

Patents Grantslast 30 patents

Inhibitors of histone deacetylase useful for the treatment or preve...

Inhibitors of histone deacetylase-3 useful for the treatment of can...

Substituted imidazo[1,2-c]quinazolines as A2A antagonists

Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine com...

Compounds that are ERK inhibitors

Heterocyclic compounds as ERK inhibitors

Compounds that are ERK inhibitors

Compounds that are ERK inhibitors

Bipiperdine derivatives useful as CCR3 antagonists

Substituted urea neuropeptide Y Y5 Receptor antagonists

Farnesyl protein transferase inhibitors

Farnesyl protein transferase inhibitors

Compounds for the inhibition of farnesyl protein transferase

Phenyl-substituted tricyclic inhibitors of farnesyl-protein transfe...

Farnesyl protein transferase inhibitors

Farnesyl protein transferase inhibitors

Phenyl-substituted tricyclic inhibitors of farnesyl-protein transfe...

Tricyclic amides useful for inhibition of G-protein function and fo...

Tricyclic amides useful for inhibition of G-protein function and fo...

Tricyclic compounds having activity as RAS-FPT inhibitors

Tricyclic compounds useful for inhibition of a g-protein function a...

Tricyclic amides useful for inhibition of G-protein function and fo...

4-substituted pyrazoloquinoline derivatives

Tricyclic compounds useful for inhibition of G-protein function and...

Tricyclic compounds useful for inhibition of g-protein function and...

4-substituted pyrazoloquinoline derivatives

Pyrazoloquinolines

4-substituted pyrazoloquinoline derivatives

4-substituted pyrazoloquinoline derivatives

Patents Applicationslast 30 patents

ADENOSINE A2A AND A2B RECEPTOR DUAL ANTAGONISTS FOR IMMUNO-ONCOLOGY

ADENOSINE A2A AND A2B RECEPTOR DUAL ANTAGONISTS FOR IMMUNO-ONCOLOGY

INHIBITORS OF HISTONE DEACETYLASE-3 USEFUL FOR THE TREATMENT OF CAN...

INHIBITORS OF HISTONE DEACETYLASE USEFUL FOR THE TREATMENT OR PREVE...

IMIDAZO[1,2-C]QUINAZOLIN-5-AMINE COMPOUNDS WITH A2A ANTAGONIST PROP...

PIPERAZINE-SUBSTITUTED [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINE COM...

NOVEL COMPOUNDS THAT ARE ERK INHIBITORS

NOVEL HETEROCYCLIC COMPOUNDS AS ERK INHBITORS

NOVEL COMPOUNDS THAT ARE ERK INHIBITORS

HETEROCYCLIC COMPOUNDS AND USE THEREOF AS ERK INHIBITORS

Novel compounds that are ERK inhibitors

Novel compounds that are ERK inhibitors

Farnesyl protein transferase inhibitors

Novel compounds that are ERK inhibitors

Piperdine derivatives useful as CCR3 antagonists

Substituted urea neuropeptide Y Y5 receptor antagonists

Substituted urea neuropeptide Y Y5 receptor antagonists

Farnesyl protein transferase inhibitors

Substituted urea neuropeptide Y Y5 receptor antagonists

Farnesyl protein transferase inhibitors